SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, today announced that it has dosed the first patient in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback